ONCY
Oncolytics Biotech Inc
NASDAQ: ONCY · HEALTHCARE · BIOTECHNOLOGY
$0.88
+1.03% today
Updated 2026-04-30
Market cap
$112.49M
P/E ratio
—
P/S ratio
58.60x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
1.1M
Oncolytics Biotech Inc (ONCY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-769.00%
ROA
-171.00%
Debt/equity
7.26x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $0.00 | $-14.30M | — | — | — |
| 2007 | $0.00 | $-15.64M | — | — | — |
| 2008 | $0.00 | $-17.55M | — | — | — |
| 2009 | $0.00 | $-17.00M | — | — | — |
| 2010 | $0.00 | $-19.97M | — | — | — |
| 2011 | $0.00 | $-29.04M | — | — | — |
| 2012 | $4.85M | $-36.37M | — | -756.22% | -749.73% |
| 2013 | $0.00 | $-23.53M | — | — | — |
| 2014 | $0.00 | $-18.62M | — | — | — |
| 2015 | $0.00 | $-13.72M | — | — | — |
| 2016 | $0.00 | $-15.14M | — | — | — |
| 2017 | $0.00 | $-15.62M | — | — | — |
| 2018 | $0.00 | $-17.04M | — | — | — |
| 2019 | $0.00 | $-45.55M | — | — | — |
| 2020 | $0.00 | $-16.78M | — | — | — |
| 2021 | $0.00 | $-20.98M | — | — | — |
| 2022 | $0.00 | $-19.08M | — | — | — |
| 2023 | $0.00 | $-20.56M | — | — | — |
| 2024 | $0.00 | $-31.71M | — | — | — |
| 2025 | $0.00 | $-28.76M | — | — | — |